THC Therapeutics (THCT) has developed a patented sanitizing cannabis dryer, the dHydronator®, which was developed specifically for drying and sanitizing freshly harvested herbs in as little as 10-14 hours. Traditional drying times take up to two weeks. In addition, this powerful, patent-pending technology has proven to destroy harmful contaminants and pathogens, which will ultimately provide a quicker and more secure return on investment for those who place their dollars in the hands of companies who utilize this system.
We like this company given their patented drying vacuum made specifically for cannabis and other herbal leaves. The potential for a technology that dries cannabis quickly is endless as it significantly reduces drying time by up to two weeks, which ultimately boosts production and the overall bottom line.
That said, with the hype of Illinois recent ruling to legalize the use and purchase of recreational marijuana begins to die down, it’s time to take a look at the cannabis boom as a whole to get a better idea as to what forward-thinking investors can expect in the coming years as this wildfire market continues to grow.
Cannabis Market Projections, 2019-2022:
Cannabis legalization is taking the investment realm by storm. Here are some quick facts as reported by Arcview Market Research and BDS Analytics:
–Germany: Having legalized medical marijuana in 2017, Germany is the second-largest international marijuana market next to the United States. The Germany cannabis market is projected to reach $1.6 billion by 2022.
–The United States: 10 States (and the District of Columbia) have legalized the recreational use of marijuana. The estimated worth of legal cannabis is over $50 billion dollars in the United States alone.
– The United States is likely to account for over 75 percent of total cannabis revenue within the next three years.
–Canada: The Canadian cannabis market is expected to reach over $5 billion dollars by 2022. It is currently valued at $600 million, providing a compounded growth rate of more than 55 percent each year.
Finding The Best Marijuana Stocks
If you’re like most investors, these projections are the fuel you need to feel confident when it comes to lighting the fire in your cannabis investment portfolio. However, before you do so, be sure to conduct the due diligence necessary to ensure a profitable investment for years to come.
Abide by the following in your search for stocks:
– Business Strategy: Although the marijuana industry is expanding exponentially, not all players are created equally. Some companies are in a better position to grow than others.
You should be sure to examine a company’s operations and business strategy and compare it to your investment motives. For example, if you’re in pursuit of a company with a global reach, a business who is focused solely on the Canadian market isn’t likely to expand to that level.
–Product Cost/Time: Research the cost factors associated with each company you are interested in investing in. Companies that grow and develop cannabis at a lower cost are more likely willing and able to compete against the bigger players.
Moreover, companies that are able to produce their product quickly and efficiently are more likely to collect a faster return on investment, which means more money in your pocket in less time.
Again, one of the best ways to achieve production efficiency is by using the THC Therapeutics dHydronator®.
–Stock Valuations: Given that the marijuana industry is relatively new, and most stocks are based on projected growth, historical data will hold less weight when compared to an industry that has been around for decades.
That said, a useful tactic for valuing a marijuana stock is the Enterprise Valuation (EV) value-to-production capacity ratio.
Enterprise value depicts a company’s total value when factoring cash, debt, and other heavy criteria.
Production capacity is the projected annual capacity for growing cannabis in kilograms.
By dividing these two values, you’re provided with a metric that allows you to compare variations in stocks against various marijuana growers.
Disclaimer: This metric should ONLY be used in conjunction with your research as the ratio is only a valuation metric dependent on other cannabis stocks.
If you’re looking for a healthy boost to your investment portfolio, cannabis could very well be it. Marijuana legalization is taking over the global market, specifically, North America, by storm. With proper research, education, and evaluation, now is a better time than any to enter into this explosive market.
Market profits are projected to reach over $50 billion in the United States alone within the next three years.
As of today, 10 states and the District of Columbia have legalized recreational cannabis use. Meanwhile, full legalization came to Canada in 2018, and other markets are not far behind.
Today we are highlighting: THC Therapeutics, Inc. (THCT), GrowGeneration Corp. (GRWG), HEXO Corp (HEXO), MJardin Group, Inc. (MJARF), and Harvest Health & Recreation Inc. (HRVSF).
THC Therapeutics, Inc. (THCT) (Market Cap: $54.39M Share Price: $3.95) has developed a sanitizing herb dryer, The dHydronator®. Their laboratory-proven product is specifically designed for drying and sanitizing freshly harvested Cannabis and herbs. THCT’s product has been tested by two independent laboratories. The testing covered over 6 strains and 9 independent tests to confirm the findings. Over the 9 tests and 6 strains, there was a 4% average increase of THC-A*. THCT recently differentiated itself when it announced the appointment of Enzo Villani to the Company’s Board of Directors. Mr. Villani has raised over $500 million in funding from strategic investors, private equity, venture capital, family offices and the public markets during his over twenty-year career. The US patent office has accepted ALL 20 claims for the dHydronator®. The company has received full patent protection for the dHydronator®. This is big. Start your research today on THCT.
GrowGeneration Corp. (GRWG) (Market Cap: $90.64M) (Share Price: $3.09) one of the largest chains of specialty hydroponic and organic garden centers, with currently 21 locations, reported financial results for its fiscal year ended December 31, 2018 in April. 2018 Financial Highlights: Revenue of $29.0 million up $14.6 million or 102% over 2017 revenues of $14.4 million. Acquired 8 stores, HeavyGardens.com and opened Oklahoma City, OK. location in 2018. Gross profit margin percentage, exclusive of inventory valuation adjustments, was
25.2% for 2018 compared to 24.2% for 2017. Store operating costs, as a percentage of revenue, have declined 13% from 20.6% for 2017 to 18% for 2018 GrowGeneration Corp., through its subsidiaries, operates retail hydroponic stores. It offers farming soil, hydroponic equipment, lighting, plant nutrients, and various other products.
HEXO Corp (HEXO) (Market Cap: $1.688B Share Price: $6.64) and Newstrike Brands Ltd.
(Newstrike) (TSX-V: HIP) had announced in March that they had entered into a definitive
arrangement agreement (the “Arrangement Agreement”) under which HEXO will acquire all of
Newstrike’s issued and outstanding common shares in an all-share transaction valued at
approximately $263 million. The Transaction gives HEXO the capacity to produce
approximately 150,000 kg of high-quality cannabis annually. The Transaction also
provides HEXO access to four cutting-edge production campuses totalling close to 1.8 million
sq. ft. of near-term cultivation space and diversified growing and production techniques. This is
in addition to HEXO’s 579,000 sq. ft. facility for a manufacturing and product development
centre of excellence in Belleville, Ontario. HEXO Corp has its headquarters in Gatineau Canada, and it produces and sells most of its cannabis products in the country. The Brantford, Ontario-based Newstrike Brands were granted a cultivation license on 16 December 2016, and the company expects its harvest to be about 42,000 kg of cannabis. Although the company has not been around for long compared to HEXO, it has a high capacity for cannabis production. HEXO recently announced that it had completed the first harvest in its 1 million sq. ft. expansion, marking an important execution milestone in the Company continuous growth.
HEXO Corp., through its subsidiary, HEXO Operations Inc., produces, markets, and sells cannabis in Canada. The company offers dried cannabis under the Time of Day and H2 lines; Elixir, a cannabis oil sublingual mist product line; and Decarb, an activated fine-milled cannabis powder product. It provides its products under the HEXO and Hydropothecary brand names. The company serves medical and adult-use markets. As one of the largest licensed cannabis
companies in Canada, HEXO Corp operates with 1.8 million sq. ft of facilities in Ontario and
Quebec and a foothold in Greece to establish a Eurozone processing, production and
MJardin Group, Inc. (MJARF) (Market Cap: $71.79M) (Share Price: $1.07), a leader in
cannabis production, recently announced the completion of an Agreement (the “Agreement”),
whereby the Nova Scotia Mi’kmaq First Nations (“Mi’kmaq”) will own a 51% stake in
AtlantiCann Medical Inc. (“AMI”). As a result of the Agreement, MJardin and the Halef Group
will own 39% and 10% of AMI, respectively. In connection with the partnership formed under
the Agreement, MJardin, the Mi’kmaq and the Halef Group are contemplating expansion of their relationship, including retail. MJardin Group, Inc., through its subsidiaries, operates as a specialized cannabis management company primarily in the United States and Canada. The company offers its partners turnkey cannabis cultivation, processing, and retail solutions.
Harvest Health & Recreation Inc. (HRVSF) (Market Cap: $1.956B) (Share Price: $6.32)
announced the granting of stock options pursuant to the stock option plan of the Corporation,
whereby the Corporation has granted a total of 12,350,250 stock options to certain officers,
directors, employees or consultants of the Corporation. This was on the heels of the
announcement that it has entered into a binding agreement to acquire Verano Holdings, LLC,
one of the largest privately held multi-state, vertically integrated licensed operator of cannabis
facilities, in an all-stock transaction for an estimated purchase price of approximately USD
$850,000,000 based on a share price of CND $8.79. Harvest Health & Recreation Inc. cultivates, manufactures, and retails cannabis in the United States. The company is headquartered in Vancouver, Canada.
This article was written by Regal Consulting, LLC (“Regal Consulting”). Regal Consulting has agreed to a three-month term consulting agreement with THCT dated 2/14/18. The agreement calls for 50,000 restricted shares of THCT per month. This agreement has been amended to $20,000 per month, and 55,000 shares per month and extended for twelve months ending 3/18/2020. All payments were made directly by THC Therapeutics, Inc. to Regal Consulting, LLC. to provide investor relations services, of which this article is a part of. Regal Consulting also paid one thousand dollars cash to microcapspeculators.com to distribute this article. Regal Consulting may have a position in the securities mentioned in this article at the time of publication, and may increase or decrease its position without notice. This article is based on public information and the opinions of Regal Consulting. THCT was given an opportunity to edit this article. This article contains forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any results predicted herein. Regal Consulting is not registered with any financial or securities regulatory authority, and does not provide or claim to provide investment advice.
Full Legal Disclaimer Click Here.
Company Name: ACR Communication LLC.
Contact Person: Media Manager
Country: United States